CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...